Clinical Trial

Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh

Study acronym: BRAVOII
Recruiting
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-02-26; most recent amendment 2026-04-29.
Status change: Not Yet Recruiting → Recruiting 2021-05-14
Trial Details
NCT Number NCT04779918
Lead Sponsor Tela Bio Inc
Collaborators: MCRA
Conditions Hernia, Ventral, Hernia, Inguinal
Enrollment 160 participants
Start Date 2021-04-29
Primary Completion 2027-03-30 (estimated)
Study Completion 2029-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-05